The primary endpoints that track response to MOTS-c therapy align with the peptide's core mechanisms: insulin sensitivity, mitochondrial function, body composition, and inflammatory tone
Binge drinking raises it dramatically
Gastric mucosal protection and intestinal barrier support effects that are uniquely relevant to the spray delivery format, as BPC-157 has demonstrated oral stability due to its gastric origin
It is a popular term for higher intestinal permeability, meaning the barrier is more open than it should be
Homocysteine reduction: NAC has been shown to lower plasma homocysteine levels by 11.5% at a dose of 1,800 mg/day in patients with hyperhomocysteinemia, likely through a disulfide exchange reaction (Ventura et al., Pharmacology, 2003) [66]